黄芪多糖促进人树突状细胞体外分化成熟的实验研究

中国临床药理学与治疗学 ›› 2010, Vol. 15 ›› Issue (12): 1348-1352.

黄芪多糖促进人树突状细胞体外分化成熟的实验研究

王琼¹, 朱学军²

¹解放军第105医院干部病房,合肥 230031,安徽;
²江苏省中医院血液科,南京 210029,江苏

收稿日期:2010-10-19 修回日期:2010-11-12 出版日期:2010-12-26 发布日期:2020-09-16
作者简介:王琼,女,硕士研究生,主治医师,目前从事老年医学工作。Tel: 13956088428 E-mail: wq7282@sohu.com

Experimental study on astragalus polysaccharides promoting the human dendritic cells maturation in vitro

WANG Qiong¹, ZHU Xue-jun²

¹Department of Cardiology,the 105 Hospital of the PLA,Hefei 230031, Anhui, China;
²Department of Hematopathy, Jiangsu Provincal Hospital of TCM, Nanjing 210029, Jiangsu, China

Received:2010-10-19 Revised:2010-11-12 Online:2010-12-26 Published:2020-09-16

摘要/Abstract

摘要： 目的: 研究黄芪多糖(APS)对人树突状细胞(DCs)体外分化成熟及存活时间的影响。方法: 健康志愿者外周血单个核细胞培养 2 h 获得贴壁的单核细胞,加入含rhGM-CSF (1000 U/mL)、rhIL-4 (500 U/mL)的无血清培养基,实验组再加入3种浓度的APS(1 μg/mL,10 μg/mL,100 μg/mL),对照组加入等体积生理盐水,一组细胞体外培养 7 d,收集悬浮细胞获得普通DCs(Mo-DCs)及APS诱导的DCs(APS-DCs),流式细胞仪测定细胞免疫表型,同种异体混和淋巴细胞反应检测DCs的免疫激活功能,另外一组细胞体外连续培养 14 d,光镜下观察细胞形态及存活时间。结果: APS能够显著促进DCs表面免疫分子 HLA-DR、CD₈₃、CD₈₀、CD₈₆、CD₄₀、CD₅₄的表达,APS-DCs 较Mo-DCs具有更强的T细胞体外激活能力,并显著延长DCs的体外存活时间达2~3 d。结论: APS可以促进DCs的成熟和延长DCs的存活时间,从而发挥增强机体免疫力的功能。

关键词: 黄芪多糖, 树突状细胞, 成熟, 免疫力

Abstract: AIM: To study the effects of astragalus polysaccharides (APS) on maturation and survival time of human dendritic cells (DCs) in vitro.METHODS: Peripheral blood mononuclear cells from healthy volunteers were cultured for 2 hours to acquire adherent monocytes. The monocytes were cultured with rhGM-CSF (1000 U/mL) and rhIL-4 (500 U/mL) in serum-free medium. The experimental groups were added three concentrations of APS (1 μg/mL, 10 μg/mL, 100 μg/mL), the control group were added equal volume of saline. One group of cells were cultured for 7 days and the cell suspension were collected to get normal DCs (Mo-DCs) or APS -induced DCs (APS-DCs) . The immunophenotyping was detected by flow cytometry, T cells stimulating activity of DCs were detected by allogeneic mixed lymphocyte reaction. Another group of cells were continuously cultured for 14 days and the cell morphology and survival time were observed under light microscope.RESULTS: APS could significantly promote the DCs surface HLA-DR, CD₈₃, CD₈₀, CD₈₆, CD₄₀, CD₅₄ expression. APS-DCs compared with Mo-DCs had a stronger T-cell activation activity. APS significantly extended the DCs survival time up to 2-3 days in vitro.CONCLUSION: APS could promote DCs maturation and extend the survival time of DCs, which may enhance the immunity.

Key words: APS, Dendritic cell, Maturation, Immunity

中图分类号:

R392.11

王琼, 朱学军. 黄芪多糖促进人树突状细胞体外分化成熟的实验研究[J]. 中国临床药理学与治疗学, 2010, 15(12): 1348-1352.

WANG Qiong, ZHU Xue-jun. Experimental study on astragalus polysaccharides promoting the human dendritic cells maturation in vitro[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2010, 15(12): 1348-1352.

参考文献

[1] 翁玲,刘学英,刘彦,等. 黄芪多糖对小鼠骨髓及外周血造血干细胞的增殖及动员作用[J]. 基础医学与临床,2003,23(3):306-309.
[2] 林爱, 李予蓉. 黄芪对小鼠免疫功能的影响[J]. 第四军医大学学报, 2003,24(17):389-391.
[3] 赵海梅, 黄小英, 刘端勇. 黄芪多糖调节免疫作用研究进展[J]. 江西中医学院学报, 2008,20(4): 75-77.
[4] 任美萍, 刘明华, 李蓉,等.黄芪多糖抗肿瘤活性研究[J].中国新药杂志,2010,19(3): 221-224.
[5] 杨丽娟, 王润田, 刘京生,等. 黄芪对S180肿瘤培养上清免疫抑制作用的影响[J]. 中国肿瘤生物治疗杂志, 2003, 10(3):210-213.
[6] 田宏印. 黄芪化学研究及其有效成分[J]. 云南民族学院学报,1996,5(1): 75-80.
[7] 朱学军, 曹雪涛, 于益芝, 等.人外周血树突状细胞的体外扩增与鉴定[J]. 中国肿瘤生物治疗杂志,1997, 4(4):302-306.
[8] Gilboa E. DC-based cancer vaccines [J]. J Clin Invest, 2007, 117(5): 1195- 1203.
[9] Rosenberg SA, Yang JC, Restifo NP. Cancer immunotherapy: moving beyond current vaccines [J]. Nat Med, 2004, 10: 909-915.
[10] Ovali E, Dikmen T, Sonmez M, et al. Active immunotherapy for cancer patients using tumor lysate pulsed dendritic cell vaccine: a safety study [J]. J Exp Clin Cancer Res, 2007, 26(2): 209-214.
[11] 朱学军. 树突状细胞疫苗治疗恶性肿瘤:挑战与希望[J].　内科理论与实践,2008, 3(2): 33-36.
[12] Vieweg J, Su Z, Dahm P, et al. Reversal of Tumor-Mediated Immuno- suppression [J]. Clin Cancer Res, 2007, 13: 727s-732s.
[13] 王前奔, 唐功耀, 赵武述,等. 黄芪对维持性血液透析病人细胞免疫功能的影响[J]. 中国免疫学杂志, 1998, 14(2): 129-131.
[14] 董竞成, 董晓辉. 黄芪注射液与白细胞介素2增强树突细胞抗肿瘤转移作用的比较研究[J].中国中西医结合杂志,2005, 25(3): 236-239.
[15] 董晓辉, 董竞成. 黄芪注射液增强树突细胞的抗肺癌作用[J] 中国实验方剂学杂志,2005, 11(1):25-28.